Surgery Partners Inc. is a healthcare services company focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of the company's patients and physicians. The company was founded in 2004 and is based in Nashville, Tennessee.
SGRY Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Surgery Partners Inc. To summarize, we found that Surgery Partners Inc ranked in the 36th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 33.67%. The most interesting components of our discounted cash flow analysis for Surgery Partners Inc ended up being:
18% of the company's capital comes from equity, which is greater than only 7.55% of stocks in our cash flow based forecasting set.
Surgery Partners Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
Relative to other stocks in its sector (Healthcare), Surgery Partners Inc has a reliance on debt greater than 96.42% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
HBIO, TARO, AMED, BDX, and LCI can be thought of as valuation peers to SGRY, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Due to the evolving public health impact of the COVID-19 pandemic, and to support the health and safety of the Company’s directors, employees and stockholders, Surgery Partners will hold its annual meeting solely by remote communication in a virtual meeting format only. Stockholders will not be able to attend the annual meeting in person.